News Content
### Drug Shelf Life and Storage Requirements The shelf life of Cerebrolysin is clearly marked on the drug packaging, and varies depending on the specification. 1ml, 2ml, 5ml, and 10ml ampoules have a shelf life of 48 months, while 20ml, 30ml, and 50ml injectable ampoules have a shelf life of 24 months. Storage must strictly follow regulations; it must be kept below 25℃, protected from light, and stored in the original packaging. It should not be refrigerated or frozen, and should also be protected from high temperatures and direct sunlight. Use immediately after opening. Failure to administer medication promptly after opening the ampoule may lead to microbial contamination and compromise medication safety.https://www.fiercerawsource.com/peptides/premium-high-purity-peptides-cerebrolysin.html
### Clinical Treatment Cycle and Duration of Efficacy Treatment cycles vary significantly across different conditions, and the duration of efficacy exceeds that of a single treatment course. For stroke and traumatic brain injury, a treatment course of 10-30 days is recommended, with daily administration rapidly improving brain metabolic disorders. Patients with dementia such as Alzheimer's disease require treatment at a rate of 4 weeks per course (5 times per week), with 2-4 courses per year. Treatment can be repeated as needed until symptoms no longer improve. Animal experiments have confirmed that cognitive function improvement in traumatic brain injury models can be maintained for more than 3 months after treatment; clinical studies show that neurological function scores continue to improve 4 weeks after treatment in patients with acute ischemic stroke.
### Precautions and Research Progress Cerebrolysin components can cross the blood-brain barrier, and neuromodulation effects can still be detected within 24 hours after a single dose. Note that this is for single use only; the catheter should be flushed with saline before and after infusion. The latest clinical research in 2025 shows that, with proper adjustment of the course and dosage, the neuroprotective effect can be further prolonged, providing support for the long-term management of cerebrovascular diseases and neurodegenerative diseases.
